why choose us

First received: August 26, 2024

Clinical Trial: Hematological Dynamic Scores for Predicting Survival and Treatment Response for Advanced Gastric Cancer After Neoadjuvant Therapy

Study Status: COMPLETED

Recruit Status: COMPLETED

Condition: Gastric Cancer

Study Type: OBSERVATIONAL


Official Title: To Develop a Prognostic Model for Predicting Survival and Treatment Response for Advanced Gastric Cancer Patients After Neoadjuvant Therapy by Analyzing Hematological Markers Dynamic Load

Brief Summary: HMDLS, based on hematological markers, could effectively distinguish the long-term efficacy of AGC patients after NAT.The predictive performance of nomogram-HMDLS was better than ypTNM stage, achieving better prognostic stratification and tumor treatment response prediction.

Read more